Literature DB >> 22944689

An ensemble view of thrombin allostery.

Bernhard C Lechtenberg1, Stefan M V Freund, James A Huntington.   

Abstract

Thrombin is the central protease of the coagulation cascade. Its activity is tightly regulated to ensure rapid blood clotting while preventing uncontrolled thrombosis. Thrombin interacts with multiple substrates and cofactors and is critically involved in both pro- and anticoagulant pathways of the coagulation network. Its allosteric regulation, especially by the monovalent cation Na(+), has been the focus of research for more than 30 years. It is believed that thrombin can adopt an anticoagulant ('slow') conformation and, after Na(+) binding, a structurally distinct procoagulant ('fast') state. In the past few years, however, the general view of allostery has evolved from one of rigid structural changes towards thermodynamic ensembles of conformational states. With this background, the view of the allosteric regulation of thrombin has also changed. The static view of the two-state model has been dismissed in favor of a more dynamic view of thrombin allostery. Herein, we review recent data that demonstrate that apo-thrombin is zymogen-like and exists as an ensemble of conformations. Furthermore, we describe how ligand binding to thrombin allosterically stabilizes conformations on the continuum from zymogen to protease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22944689     DOI: 10.1515/hsz-2012-0178

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  28 in total

1.  Visualizing correlated motion with HDBSCAN clustering.

Authors:  Ryan L Melvin; Jiajie Xiao; Ryan C Godwin; Kenneth S Berenhaut; Freddie R Salsbury
Journal:  Protein Sci       Date:  2017-09-06       Impact factor: 6.725

2.  Mechanistic insights into thrombin's switch between "slow" and "fast" forms.

Authors:  Jiajie Xiao; Ryan L Melvin; Freddie R Salsbury
Journal:  Phys Chem Chem Phys       Date:  2017-09-20       Impact factor: 3.676

3.  Polyphosphate suppresses complement via the terminal pathway.

Authors:  Jovian M Wat; Jonathan H Foley; Michael J Krisinger; Linnette Mae Ocariza; Victor Lei; Gregory A Wasney; Emilie Lameignere; Natalie C Strynadka; Stephanie A Smith; James H Morrissey; Edward M Conway
Journal:  Blood       Date:  2013-12-13       Impact factor: 22.113

Review 4.  Dynamic multiprotein assemblies shape the spatial structure of cell signaling.

Authors:  Ruth Nussinov; Hyunbum Jang
Journal:  Prog Biophys Mol Biol       Date:  2014-07-18       Impact factor: 3.667

5.  Sodium entry through endothelial store-operated calcium entry channels: regulation by Orai1.

Authors:  Ningyong Xu; Donna L Cioffi; Mikhail Alexeyev; Thomas C Rich; Troy Stevens
Journal:  Am J Physiol Cell Physiol       Date:  2014-11-26       Impact factor: 4.249

6.  Designing allosteric regulators of thrombin. Exosite 2 features multiple subsites that can be targeted by sulfated small molecules for inducing inhibition.

Authors:  Preetpal Singh Sidhu; May H Abdel Aziz; Aurijit Sarkar; Akul Y Mehta; Qibing Zhou; Umesh R Desai
Journal:  J Med Chem       Date:  2013-06-13       Impact factor: 7.446

7.  Deciphering Conformational Changes Associated with the Maturation of Thrombin Anion Binding Exosite I.

Authors:  Ramya Billur; David Ban; T Michael Sabo; Muriel C Maurer
Journal:  Biochemistry       Date:  2017-11-21       Impact factor: 3.162

8.  A small group of sulfated benzofurans induces steady-state submaximal inhibition of thrombin.

Authors:  Daniel K Afosah; Stephen Verespy; Rami A Al-Horani; Rio S Boothello; Rajesh Karuturi; Umesh R Desai
Journal:  Bioorg Med Chem Lett       Date:  2018-02-03       Impact factor: 2.823

9.  The spatial structure of cell signaling systems.

Authors:  Ruth Nussinov
Journal:  Phys Biol       Date:  2013-08-02       Impact factor: 2.583

10.  Substantial non-electrostatic forces are needed to induce allosteric disruption of thrombin's active site through exosite 2.

Authors:  Akul Y Mehta; Umesh R Desai
Journal:  Biochem Biophys Res Commun       Date:  2014-09-06       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.